The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPH.L Share News (MPH)

  • There is currently no data for MPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Stobart Adds Former Luton Airport Head

Tue, 30th Jun 2020 18:24

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Tuesday and not separately reported by Alliance News:

----------

Kingfisher PLC - London-based DIY store chain - Hires Tony Buffin as non-executive director from December 1. Buffin is chief executive officer of health food stores chain Holland & Barrett and prior to that chief operating officer & chief financial officer of builders' merchant Travis Perkins PLC and CFO of Australian grocer Coles Group.

----------

Stobart Group Ltd - aviation and energy infrastructure, including operating London Southend Airport - Hires Clive Condie as non-executive director. Condie is the former chair and interim CEO of London Luton Airport, having worked for British Airways and Manchester Airport

----------

Mereo Biopharma Group PLC - London-based clinical-stage biopharmaceutical company focused on oncology and rare diseases - Appoints John Lewicki as chief scientific officer and Ann Kapoun as senior vice president of Translational Research & Development. Both joined Mereo from OncoMed Pharmaceuticals following 2019 merger between the two companies, and both were involved in the development of Mereo's lead oncology product candidate, etigilimab.

----------

Dukemount Capital PLC - London-based property management firm - Hires Matthew Thompson as chief executive. Notes Thompson has 17 years of private equity, family office, legal, energy and real estate experience.

----------

Equals Group PLC - London-based e-banking and international payments - John Pearson steps down as non-executive chair at Tuesday's annual general meeting. Alan Hughes, who joined the board as a non-executive director in February, steps up to chair. Hughes is the former chief executive of UK challenger bank First Direct.

----------

US Solar Fund PLC - investor in solar power assets in North America - Hires Thomas Plagemann as independent non-executive director, effective immediately. Plagemann is chief commercial officer and head of capital markets at Vivint Solar.

----------

Uniphar PLC - Dublin-based healthcare services - Mark Moran to step down from board on September 1. Moran joined the board as a representative of the Sisk Family following the acquisition of Sisk Healthcare Group in 2018. Ger Penny, another Sisk Family representative, remains as non-executive director.

----------

San Leon Energy PLC - oil explorer and producer focused on Nigeria - Mark Phillips steps down as non-executive director immediately, after four years on board. San Leon adds it is in the "latter stages of the appointment process" for a new nominated advisor to replace Cantor Fitzgerald Europe. Expects to appoint at least one new non-executive director at that time.

----------

Oakley Capital Investments Ltd - investment vehicle providing access to the Oakley private equity funds - Craig Bodenstab resigns as independent non-executive director immediately due to "a significant and unplanned increase in his other commitments". Will appoint a replacement shortly.

----------

European Metals Holdings Ltd - Cinovec lithium-tin project in Czech Republic - David Reeves resigns as non-executive chair, effective immediately, "to concentrate on his other business interests". Managing Director Keith Coughlan is named executive chair on an interim basis.

----------

Malvern International PLC - London-based learning and skills development - Richard Mace appointed as chief executive officer following equity raise last week. Mace holds a 7.2% stake in Malvern. The company raised GBP1.3 million from the issue of 766.7 million shares, 69% of its enlarged capital. It also restructured existing debt with Boost & Co. Mace is the founder of Communicate English School Ltd, which operated a school in Manchester and was acquired by Malvern in 2018. Mace continued to run the school but had left Malvern this past March.

----------

Wey Education PLC - London-based education services - Erica Pienaar retires as non-executive director, effective immediately, "to focus on her personal interests". Says will appoint new non-executive director in due course.

----------

Walcom Group Ltd - China-focused animal feeds - Franky Wong and Albert Chi Chiu Wong to step down as independent non-executive directors from Wednesday. Walcom shares were suspended from trading on AIM last week after Allenby Capital Ltd resigned as nominated advisor and broker. Still awaiting payment of loan from Chief Executive Francis Chi.

----------

Maintel Holdings PLC - London-based cloud and managed service provider - Kevin Stevens resigns as chief operating officer and Stuart Legg as sales director and leave company with immediate effect. No reason provided, but Maintel says the board is "keen to record" its thanks for their contributions to the business.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Sep 2019 11:53

Mereo BioPharma Loss Narrows On Gain From OncoMed Buy And Expenses

(Alliance News) - Mereo BioPharma Group PLC on Tuesday posted a slightly narrowed loss for the first half of 2019 on a gain from its OncoMed Pharmaceuticals Inc acquisition, as well as lower in at

Read more
16 Aug 2019 15:32

DIRECTOR DEALINGS: Mereo BioPharma Trio Of Directors Acquire Shares

(Alliance News) - Mereo BioPharma Group PLC on Friday said General Counsel Charles Sermon, Chief Executive Officer Denise Scots-Knight and Head of Corporate Development John Richard, all purchased

Read more
16 Jul 2019 14:46

Mereo BioPharma Names Richard Francis As New Pharmaceutical Head

(Alliance News) - Mereo BioPharma has appointed Richard Francis as the new head of pharmaceutical development, effective August 1, the biopharmaceutical company said on Tuesday.Francis was

Read more
12 Jun 2019 16:04

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 13 JuneTescoWM Morrison SupermarketsSirius MineralsJust Jack 14 Evans 17 18

Read more
30 May 2019 10:52

Mereo BioPharma Reports Positive Data For Anti-Sclerostin Antibody

LONDON (Alliance News) - Mereo BioPharma Group PLC on Thursday reported positive six-month data for its anti-sclerostin antibody, BPS-804, in the treatment of adult patients with osteogenesis were

Read more
30 May 2019 10:40

Mereo BioPharma releases 'encouraging' data from setrusumab study

(Sharecast News) - Clinical stage biopharmaceutical company Mereo BioPharma Group announced encouraging six-month data from the open label arm of its phase 2b dose-ranging clinical study in adults with type I, III or IV osteogenesis imperfecta (OI) treated with BPS-804 ('setrusumab'), or the 'ASTEROID' study, on Thursday.

Read more
23 May 2019 17:58

DIRECTOR DEALINGS: Mereo Biopharma Non-Executive Bains Buys Shares

LONDON (Alliance News) - Mereo Biopharma PLC said Thursday that Non-Executive Director Peter Bains purchased around GBP42,750 in stock in a deal on Tuesday.Bains bought 47,500 shares at a

Read more
29 Apr 2019 12:05

Mereo BioPharma Set For Transformational 2019 As Loss Narrows Sharply

LONDON (Alliance News) - Mereo BioPharma Group PLC on Monday said its loss narrowed in 2018 following the completion of several product trials.The clinical stage biopharmaceutical company a

Read more
23 Apr 2019 14:48

Mereo BioPharma Completes Merger With OncoMed Pharmaceuticals

LONDON (Alliance News) - Mereo BioPharma Group PLC on Tuesday said its all-stock merger with OncoMed Pharmaceuticals Inc is now complete.OncoMed's shareholders approved the deal on last

Read more
18 Apr 2019 11:37

OncoMed Shareholders Approve All-Share Merger With Mereo BioPharma

LONDON (Alliance News) - Mereo BioPharma Group PLC on Thursday said OncoMed Pharmaceuticals Inc shareholders have approved the merger of the two companies.Mereo BioPharma, a clinical stage

Read more
15 Apr 2019 10:07

Mereo Agrees With US FDA On Phase Three Trial Design For Acumapimod

LONDON (Alliance News) - Mereo BioPharma Group PLC said on Monday it has concluded an end of Phase Two meeting with the US Food & Drug Administration regarding acumapimod as a treatment for of

Read more
15 Mar 2019 16:57

Mereo BioPharma Scures Further Acceptances From OncoMed Shareholders

LONDON (Alliance News) - Mereo BioPharma Group PLC on Friday said it has now received support agreements in respect of 21.1% of OncoMed Pharmaceuticals Inc's shares and expects to complete the

Read more
15 Mar 2019 15:16

Mereo BioPharma merger with OncoMed moves closer

(Sharecast News) - Clinical-stage biopharmaceutical company Mereo BioPharma Group updated the market on its proposed combination with OncoMed Pharmaceuticals on Friday, which it said should close in the second quarter of 2019.

Read more
22 Feb 2019 14:35

Mereo BioPharma Withdraws US Listing Application On OncoMed Deal (ALLIPO)

LONDON (Alliance News) - Mereo BioPharma Group PLC said Friday it has requested the withdrawal of its US IPO application as it continues to work on its business combination with US pharmaceutical

Read more
11 Feb 2019 12:44

Mereo BioPharma Founding Director Departs Before OncoMed Combination

LONDON (Alliance News) - Mereo BioPharma Group PLC on Monday announced the immediate departure of founding board director Frank Armstrong prior to Mereo's combination with US firm OncoMed was

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.